Skip to main content

Short-Term Exposure to Air Pollutants Linked to Incidence of Stroke

Medically reviewed by Drugs.com.

By Elana Gotkine HealthDay Reporter

THURSDAY, Sept. 28, 2023 -- There is a significant association between short-term exposure to air pollutants and the incidence and mortality rate of stroke, according to a review published online Sept. 27 in Neurology.

Ahmad Toubasi, M.D., and Thuraya N. Al-Sayegh, M.D., from the University of Jordan in Amman, conducted a systematic review and meta-analysis to examine the correlation between short-term exposure to air pollutants and stroke. A total of 110 observational studies, with 18,035,408 cases of ischemic stroke, were included in the analysis. Short-term exposure was defined as exposure within five days of stroke onset.

The researchers found that stroke incidence was significantly associated with an increase in the concentration of nitrogen dioxide (NO2), ozone, carbon monoxide, sulfur dioxide (SO2), and particulate matter with diameters of less than 1.0 µm, less than 2.5 µm (PM2.5), and less than 10 µm (PM10; relative risks, 1.28, 1.05, 1.26, 1.15, 1.09, 1.15, and 1.14, respectively). In addition, significant associations were seen for increases in the concentration of NO2, SO2, PM2.5, and PM10 with increased stroke mortality (relative risks, 1.33, 1.60, 1.09, and 1.02, respectively).

"There is a strong and significant association between air pollution and the occurrence of stroke as well as death from stroke within five days of exposure," Toubasi said in a statement. "This highlights the importance of global efforts to create policies that reduce air pollution. Doing so may reduce the number of strokes and their consequences."

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Read this next

AI-Assisted Contours Superior to Cognitively Defined Prostate Cancer Contours

WEDNESDAY, July 3, 2024 -- Artificial intelligence (AI)-assisted definition of prostate cancer contours reduces underestimation of the extent of prostate cancer, according to a...

Mean Cost of Bringing New Drug to U.S. Market Is $879.3 Million

TUESDAY, July 2, 2024 -- The mean cost of developing a new drug for the U.S. market is estimated to be $879.3 million when both drug development failure and capital costs are...

Patient–Primary Care Provider Language Concordance Tied to Better Outcomes

TUESDAY, July 2, 2024 -- Patient-family physician language concordance is associated with a lower risk for adverse outcomes, according to a study published online June 3...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.